Response and Adverse Effects of Nilotinib in Imatinib-Resistant Chronic Myeloid Leukemia Patients: Data From a Developing Country
Clin Ther
.
2016 Mar;38(3):681-2.
doi: 10.1016/j.clinthera.2016.01.002.
Epub 2016 Jan 28.
Authors
Shabneez Hussain
1
,
Usman Shaikh
1
Affiliation
1
Department of Hematology, The Aga Khan University and Hospital, Karachi, Pakistan.
PMID:
26831828
DOI:
10.1016/j.clinthera.2016.01.002
No abstract available
Publication types
Letter
Comment
MeSH terms
Antineoplastic Agents / therapeutic use*
Female
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
Male
Pyrimidines / therapeutic use*
Substances
Antineoplastic Agents
Pyrimidines